Michael Braun

Michael Braun serves as Senior Venture Partner at 415C. Michael is a distinguished biomedical engineer, inventor, and holder of several medical device patents. At 415C, Michael is intimately involved in the technical evaluation of new portfolio prospects. He serves as CEO of CoRRect Medical GmbH (acquired by Uniphar PLC in 2021) which he co-founded with Frank Groenewegen and David Thompson in 2010. Michael is also the founder and CEO of Symedrix GmbH, a German manufacturer of specialty guidewires for minimally invasive cardiac procedures. Previously, Michael co-founded Reverse Medical Corp. and acted as R&D Director for the Neuroradiology product line prior to acquisition by Covidien in 2015 (now part of Medtronic).

Michael co-founded several successful medical device distribution and consulting companies, providing clinical trial and regulatory support to dozens of startups. Previously, Michael held several roles at Medtronic, most recently as Clinical Specialist for the Endovascular Aneurysm Repair (EVAR) and Peripheral product lines. He started his engineering career in the R&D Department of Biomechanics & Prosthetics at Rüsch AG / Teleflex where he invented the Polyflex™ stent. Mr. Braun holds a B.Sc. in Biomedical Engineering from the University of Aachen, Germany.